ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.8M
1-Year Return
57.47%
This Quarter Return
+11.38%
1 Year Return
+57.47%
3 Year Return
+81.9%
5 Year Return
+179.01%
10 Year Return
–
AUM
$2.03B
AUM Growth
+$28.7M
(+1.4%)
Cap. Flow
-$82.7M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
7.55%
Holding
1,939
New
551
Increased
357
Reduced
377
Closed
648
Top Buys
| 1 |
United Airlines
UAL
|
+$12.7M |
| 2 |
Ulta Beauty
ULTA
|
+$10.4M |
| 3 |
Stryker
SYK
|
+$10.3M |
| 4 |
Global Payments
GPN
|
+$10M |
| 5 |
Gilead Sciences
GILD
|
+$9.48M |
Top Sells
| 1 |
Union Pacific
UNP
|
+$15.6M |
| 2 |
Morgan Stanley
MS
|
+$15M |
| 3 |
Netflix
NFLX
|
+$13.3M |
| 4 |
Lowe's Companies
LOW
|
+$13.2M |
| 5 |
Capital One
COF
|
+$12M |
Sector Composition
| 1 | Technology | 15.87% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.61% |
| 4 | Industrials | 11.99% |
| 5 | Financials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Copel
ELP
$6.84B
| $404K | 0.02% |
59,560
+24,992
| +72% | +$170K |
|
|
TARO
927
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $404K | 0.02% |
4,590
+100
| +2% | +$8.8K |
|
|
HABT
928
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $404K | 0.02% |
38,770
-26,300
| -40% | -$274K |
|
929
McGrath RentCorp
MGRC
$3.02B
| $403K | 0.02% |
5,265
-1,600
| -23% | -$122K |
|
930
Kura Oncology
KURA
$709M
| $402K | 0.02% |
+29,257
| New | +$402K |
|
|
GOGL
931
DELISTED
Golden Ocean Group
GOGL
| $400K | 0.02% |
+68,921
| New | +$400K |
|
932
Veracyte
VCYT
$2.42B
| $400K | 0.02% |
+14,338
| New | +$400K |
|
933
Empire State Realty Trust
ESRT
$1.3B
| $398K | 0.02% |
+28,500
| New | +$398K |
|
934
Expro
XPRO
$1.42B
| $397K | 0.02% |
12,787
-6,750
| -35% | -$210K |
|
935
CoreCard
CCRD
$208M
| $396K | 0.02% |
+9,912
| New | +$396K |
|
|
REV
936
DELISTED
Revlon, Inc.
REV
| $395K | 0.02% |
+18,433
| New | +$395K |
|
937
Stantec
STN
$12.4B
| $393K | 0.02% |
+13,873
| New | +$393K |
|
938
National Bank Holdings
NBHC
$1.47B
| $389K | 0.02% |
11,031
-11,700
| -51% | -$413K |
|
|
KRA
939
DELISTED
Kraton Corporation
KRA
| $387K | 0.02% |
15,266
-18,200
| -54% | -$461K |
|
940
CVS Health
CVS
$93.8B
| $385K | 0.02% |
5,179
-81,900
| -94% | -$6.09M |
|
941
Interface
TILE
$1.6B
| $385K | 0.02% |
+23,214
| New | +$385K |
|
|
LHCG
942
DELISTED
LHC Group LLC
LHCG
| $384K | 0.02% |
2,789
-2,400
| -46% | -$330K |
|
943
Axogen
AXGN
$739M
| $384K | 0.02% |
21,467
-24,415
| -53% | -$437K |
|
944
3D Systems Corporation
DDD
$272M
| $384K | 0.02% |
+43,867
| New | +$384K |
|
|
CBAY
945
DELISTED
Cymabay Therapeutics
CBAY
| $383K | 0.02% |
195,480
+153,541
| +366% | +$301K |
|
|
APTO
946
DELISTED
Aptose Biosciences, Inc.
APTO
| $383K | 0.02% |
+150
| New | +$383K |
|
947
Caesarstone
CSTE
$50.5M
| $382K | 0.02% |
+25,327
| New | +$382K |
|
948
Enanta Pharmaceuticals
ENTA
$178M
| $382K | 0.02% |
6,183
-10,964
| -64% | -$677K |
|
949
Horizon Bancorp
HBNC
$839M
| $382K | 0.02% |
20,084
+5,000
| +33% | +$95.1K |
|
|
TVRD
950
Tvardi Therapeutics, Inc. Common Stock
TVRD
$308M
| $382K | 0.02% |
+659
| New | +$382K |
|